The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
- Status
- RECRUITING
- Phase
- NA
The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy
- Status
- RECRUITING
- Phase
- NA
A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
SL-28 for Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Status
- RECRUITING
- Phase
- PHASE3
Sample Collection for Ongoing Research and Product Evaluation Study
- Status
- RECRUITING
- Phase
- N/A
A Study of Isoquercetin in People With Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line Treatment
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1